However, later evidence indicates that ERK activation is largely restricted to astroglial cells in the early stages of AD, followed by the loss of active ERK in advanced AD and limited activity in neuronal populations (Webster et al, 2006). The gene discussed is MAPK1; the disease is Alzheimer disease.